Tryp Therapeutics Probability of Future OTC Stock Price Finishing Under 0.059
| TRYPFDelisted Stock | USD 0.05 0 6.89% |
Tryp |
Tryp Therapeutics Target Price Odds to finish below 0.059
The tendency of Tryp OTC Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to stay under $ 0.06 after 90 days |
| 0.05 | 90 days | 0.06 | about 62.41 |
Based on a normal probability distribution, the odds of Tryp Therapeutics to stay under $ 0.06 after 90 days from now is about 62.41 (This Tryp Therapeutics probability density function shows the probability of Tryp OTC Stock to fall within a particular range of prices over 90 days) . Probability of Tryp Therapeutics price to stay between its current price of $ 0.05 and $ 0.06 at the end of the 90-day period is about 46.37 .
Assuming the 90 days horizon Tryp Therapeutics has a beta of 0.13. This usually implies as returns on the market go up, Tryp Therapeutics average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Tryp Therapeutics will be expected to be much smaller as well. Additionally Tryp Therapeutics has an alpha of 0.928, implying that it can generate a 0.93 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Tryp Therapeutics Price Density |
| Price |
Predictive Modules for Tryp Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Tryp Therapeutics. Regardless of method or technology, however, to accurately forecast the otc stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the otc stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Tryp Therapeutics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Tryp Therapeutics is not an exception. The market had few large corrections towards the Tryp Therapeutics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Tryp Therapeutics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Tryp Therapeutics within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.93 | |
β | Beta against Dow Jones | 0.13 | |
σ | Overall volatility | 0.01 | |
Ir | Information ratio | 0.06 |
Tryp Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Tryp Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Tryp Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Tryp Therapeutics is not yet fully synchronised with the market data | |
| Tryp Therapeutics has some characteristics of a very speculative penny stock | |
| Tryp Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (7.49 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Tryp Therapeutics has accumulated about 2.85 M in cash with (5.81 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.03. | |
| Roughly 47.0% of the company outstanding shares are owned by corporate insiders |
Tryp Therapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Tryp OTC Stock often depends not only on the future outlook of the current and potential Tryp Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Tryp Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 96.4 M |
Tryp Therapeutics Technical Analysis
Tryp Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. Tryp OTC Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Tryp Therapeutics. In general, you should focus on analyzing Tryp OTC Stock price patterns and their correlations with different microeconomic environments and drivers.
Tryp Therapeutics Predictive Forecast Models
Tryp Therapeutics' time-series forecasting models is one of many Tryp Therapeutics' otc stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Tryp Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the otc stock market movement and maximize returns from investment trading.
Things to note about Tryp Therapeutics
Checking the ongoing alerts about Tryp Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Tryp Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Tryp Therapeutics is not yet fully synchronised with the market data | |
| Tryp Therapeutics has some characteristics of a very speculative penny stock | |
| Tryp Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (7.49 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Tryp Therapeutics has accumulated about 2.85 M in cash with (5.81 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.03. | |
| Roughly 47.0% of the company outstanding shares are owned by corporate insiders |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Consideration for investing in Tryp OTC Stock
If you are still planning to invest in Tryp Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Tryp Therapeutics' history and understand the potential risks before investing.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |